$493 Million is the total value of Samsara BioCapital, LLC's 44 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NKTX | Nkarta, Inc. | $125,073,000 | +104.5% | 2,034,703 | 0.0% | 12.58% | -26.3% | |
| STRO | Sutro BioPharma Inc | $36,377,000 | +116.0% | 1,675,579 | 0.0% | 3.66% | -22.1% | |
| ODT | Odonate Therapeutics Inc | $15,656,000 | +43.0% | 815,421 | 0.0% | 1.57% | -48.5% | |
| ICPT | Intercept Pharmaceuticals Inc | $9,971,000 | -40.4% | 403,688 | 0.0% | 1.00% | -78.5% | |
| VRNA | Verona Pharma PLC.spons ads | $7,778,000 | +12.2% | 1,111,112 | 0.0% | 0.78% | -59.6% | |
| AGLE | Aeglea BioTherapeutics, Inc. | $6,955,000 | +11.0% | 883,720 | 0.0% | 0.70% | -60.0% | |
| EQ | Equillium, Inc. | $5,747,000 | -7.3% | 1,074,285 | 0.0% | 0.58% | -66.6% | |
| BCTG | BCTG Acquisition Corp | $5,720,000 | +10.4% | 500,000 | 0.0% | 0.58% | -60.2% | |
| PANAU | Panacea Acquisition Corp.unit | $5,104,000 | +6.3% | 400,000 | 0.0% | 0.51% | -61.7% | |
| ALBO | Albireo Pharma, Inc. | $3,751,000 | +12.4% | 100,000 | 0.0% | 0.38% | -59.5% | |
| FULC | Fulcrum Therapeutics, Inc. | $3,444,000 | +47.7% | 294,118 | 0.0% | 0.35% | -46.8% | |
| Catabasis Pharmaceuticals Inc | $642,000 | -65.4% | 300,000 | 0.0% | 0.06% | -87.5% | ||
| AMRN | Amarin Corp PLCspons adr new | $122,000 | +16.2% | 25,000 | 0.0% | 0.01% | -58.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.